Search Tag: cancer diagnosis

Executive Health Management

Lockdowns-linked-to-skin-cancer-delays-costing-eur7bn-in-europe

2024 17 Feb

  Delays in the diagnosis of skin cancer, attributed to the COVID-19 lockdowns, have resulted in an estimated 100,000 years of life being lost and a financial impact of €7.1 billion across Europe, a recent study suggests.   This research, disclosed last Friday in the Jama Network Open journal, underscores the severe outcomes of the 2020 and...Read more

Executive Health Management

Anxious-patients-may-prefer-to-receive-biopsy-results-by-phone

2015 07 Apr

Physicians are taught to deliver the results of patients’ biopsies in person, but a survey of patients at three US melanoma clinics indicates that many patients prefer an expedient phone call to the longer wait associated with a face-to-face follow-up visit. “We thought they would want it to be in person or by email, but it turned out that the phone...Read more

Executive Health Management

Measuring-physician-compassion-patients-respond-to-optimism

2015 26 Feb

Many physicians struggle to deliver bad news to cancer patients. They must balance the need to honestly inform patients about their prognoses while expressing empathy. According to new research, cancer patients who are given an optimistic message from their doctors which includes possible future treatment options are more likely to perceive a higher...Read more

Executive Health Management

Volitionrx-and-university-hospital-bonn-collaborate-on-cancer-diagnostic-test-evaluation

2014 25 Apr

The agreement includes CE Mark performance evaluation and doubles the Hospital’s prospective trial of 20 cancers, adding a range of additional vital background work   VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, has announced that VolitionRx has extended its agreement...Read more

Executive Health Management

Novel-device-to-analyse-biopsy-diagnose-cancer-in-minutes

2014 07 Feb

Currently being developed by University of Washington scientists and engineers, a novel, credit-card sized, low cost device could assist pathologists in their analysis of biopsies and the subsequent diagnosis of pancreatic cancer in an earlier and faster manner than ever before.  The prototype is able to conduct basic steps required for processing...Read more